The effectivness of Group Spiritual Therapy on Health Status ,Coping strategies & SerumT Lymphocyt Immune System in Women With Breast Cancer.

Not Applicable

Conditions: Breast cancer.

Registration Number: IRCT20190508043520N1

Lead Sponsor: Boushehr University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

breast cancer diagnosis from oncologist.
being at clinical stage I , II , or III
no metastatic lesion.
Age between 30 to 59 years
??At least 8 months after diagnosis and termination of acute treatment period such as surgery, chemotherapy, and radiation therapy which are effective in psycho-spiritual aspect and may have caused some bias in the study.
having literacy
having letter of satisfaction
no history of psychotropic drug use, and no history of alcohol used or smoked during the 3 months before the study.
no history of other neurosis or psychosis before diagnosis , such as depression and schizophrenia..
no history of other chronic diseases.
no history of other cancer during 10 years.
no history of psycho- spiritual education .

Exclusion Criteria

dissatisfaction to participate in research
any disability to be present in sessions intervention
those with history of cognitive disorder,confusion or cerebral injury.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health Status. Timepoint: Study of Health Status at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention) . Method of measurement: WHO Individual Questionnaire 2016.;Coping strategies. Timepoint: Study of Coping strategies at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention) . Method of measurement: Lazarus & Folkman coping strategy questionnaire 1988.;Serum T Lymphocyte Immune System. Timepoint: Measure Serum T Lymphocyte Immune System at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention). Method of measurement: 5 cc blood was obtained from participants & test analyzed by flow cytometry.

Secondary Outcome Measures